Financial Ratios

CARE INSTITUTE OF MEDICAL SCIENCES LTD.

NSE : NABSE : 523234ISIN CODE : Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.30-0.30-0.31-0.44-0.68
   CEPS(Rs)0.040.030.03-0.10-0.22
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-17.34-17.04-16.74-16.43-16.00
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)3.535.374.83-34.26-52.10
   EBIT Margin(%)-54.65-55.54-56.11-102.25-158.62
   Pre Tax Margin(%)-54.65-55.54-56.11-102.25-158.62
   PAT Margin (%)-54.65-55.54-56.11-102.25-158.62
   Cash Profit Margin (%)6.805.915.34-23.65-50.89
Performance Ratios
   ROA(%)-8.20-7.72-7.27-9.67-13.88
   ROE(%)0.000.000.000.000.00
   ROCE(%)-11.28-10.30-9.43-12.05-16.21
   Asset Turnover(x)0.150.140.130.090.09
   Sales/Fixed Asset(x)0.020.020.020.020.02
   Working Capital/Sales(x)-0.78-0.70-0.68-0.52-0.61
Efficiency Ratios
   Fixed Capital/Sales(x)42.6842.6842.6854.5954.59
   Receivable days0.000.000.000.000.00
   Inventory Days0.000.000.000.000.00
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)54.1454.3154.3769.6269.69
   EV/Core EBITDA(x)796.18918.521018.64-294.37-136.96
   EV/EBIT(x)-99.08-97.80-96.90-68.09-43.94
   EV/CE(x)8.467.847.296.816.37
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)0.000.0027.910.00
   Core EBITDA Growth(%)15.0110.78128.8753.52-626.18
   EBIT Growth(%)1.601.0329.8135.54-11.33
   PAT Growth(%)1.601.0329.8135.54-11.26
   EPS Growth(%)1.601.0329.8135.54-11.26
Financial Stability Ratios
   Total Debt/Equity(x)-1.14-1.16-1.18-1.21-1.24
   Current Ratio(x)0.300.210.180.150.14
   Quick Ratio(x)0.300.210.180.150.14
   Interest Cover(x)
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.